MFG Wealth Management Inc. cut its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 44.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,179 shares of the company's stock after selling 10,550 shares during the period. MFG Wealth Management Inc.'s holdings in Docusign were worth $1,027,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Hemington Wealth Management boosted its holdings in shares of Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the period. Banque Transatlantique SA bought a new stake in Docusign in the 1st quarter valued at about $26,000. Golden State Wealth Management LLC lifted its position in Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after purchasing an additional 322 shares during the last quarter. Summit Securities Group LLC bought a new stake in Docusign in the 1st quarter valued at about $34,000. Finally, Wood Tarver Financial Group LLC bought a new stake in shares of Docusign during the 4th quarter worth about $37,000. 77.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have commented on DOCU shares. Royal Bank Of Canada boosted their price target on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a research report on Friday, September 5th. Robert W. Baird boosted their price target on shares of Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a research report on Friday, September 5th. Wedbush dropped their price target on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday, June 12th. Finally, Zacks Research upgraded shares of Docusign from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, September 9th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $94.14.
Check Out Our Latest Stock Analysis on DOCU
Docusign Price Performance
Shares of DOCU traded down $0.42 during mid-day trading on Friday, hitting $84.59. The company's stock had a trading volume of 4,516,106 shares, compared to its average volume of 3,404,911. The firm has a 50-day moving average price of $76.39 and a 200 day moving average price of $79.30. The stock has a market capitalization of $17.01 billion, a price-to-earnings ratio of 63.60, a PEG ratio of 4.46 and a beta of 1.02. Docusign Inc. has a fifty-two week low of $57.58 and a fifty-two week high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million for the quarter, compared to analysts' expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business's revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.
Docusign declared that its board has authorized a stock repurchase program on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its stock is undervalued.
Insiders Place Their Bets
In other news, CFO Blake Jeffrey Grayson sold 9,509 shares of Docusign stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $790,197.90. Following the transaction, the chief financial officer directly owned 112,160 shares of the company's stock, valued at $9,320,496. This trade represents a 7.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Robert Chatwani sold 13,817 shares of Docusign stock in a transaction that occurred on Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the completion of the transaction, the insider directly owned 71,162 shares in the company, valued at approximately $5,913,562.20. This trade represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 82,533 shares of company stock valued at $6,598,028 over the last 90 days. 1.01% of the stock is owned by corporate insiders.
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.